News Release

Outcomes of dexamethasone treatment after hospital discharge for patients with COVID-19

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

What The Study Did: This study of 1,164 patients with COVID-19 assessed whether continuing treatment with the corticosteroid dexamethasone at hospital discharge was associated with reduced readmissions or mortality within 14 days from discharge.

Authors: Cheng-Wei Huang, M.D., of the Kaiser Permanente Los Angeles Medical Center, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  

(doi:10.1001/jamanetworkopen.2022.1455)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.1455?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=030822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.